Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

  1. Wolff, I.
  2. May, M.
  3. Hoschke, B.
  4. Zigeuner, R.
  5. Cindolo, L.
  6. Hutterer, G.
  7. Schips, L.
  8. De Cobelli, O.
  9. Rocco, B.
  10. De Nunzio, C.
  11. Tubaro, A.
  12. Coman, I.
  13. Feciche, B.
  14. Truss, M.
  15. Dalpiaz, O.
  16. Figenshau, R.S.
  17. Madison, K.
  18. Sánchez-Chapado, M.
  19. Santiago Martin, M.D.C.
  20. Salzano, L.
  21. Lotrecchiano, G.
  22. Shariat, S.F.
  23. Hohenfellner, M.
  24. Waidelich, R.
  25. Stief, C.
  26. Miller, K.
  27. Pahernik, S.
  28. Brookman-May, S.
  29. Mostrar todos os autores +
Revista:
European Journal of Surgical Oncology

ISSN: 1532-2157 0748-7983

Ano de publicación: 2016

Volume: 42

Número: 5

Páxinas: 744-750

Tipo: Artigo

DOI: 10.1016/J.EJSO.2016.01.009 GOOGLE SCHOLAR